药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Alprenolol
Metiamide
Metiamide can cause a decrease in the absorption of Darunavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Alprenolol
Calcium carbonate
Calcium carbonate can cause a decrease in the absorption of Darunavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Alprenolol
Aluminum hydroxide
Aluminum hydroxide can cause a decrease in the absorption of Darunavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Alprenolol
Sodium bicarbonate
Sodium bicarbonate can cause a decrease in the absorption of Darunavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Alprenolol
Magnesium oxide
Magnesium oxide can cause a decrease in the absorption of Darunavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Alprenolol
Aluminium
Aluminium can cause a decrease in the absorption of Darunavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Alprenolol
Methantheline
Methantheline can cause a decrease in the absorption of Darunavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Alprenolol
Pitavastatin
The serum concentration of Pitavastatin can be decreased when it is combined with Darunavir.
Alprenolol
Cholestyramine
Cholestyramine can cause a decrease in the absorption of Darunavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Alprenolol
Colesevelam
Colesevelam can cause a decrease in the absorption of Darunavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Alprenolol
Revefenacin
Darunavir may decrease the excretion rate of Revefenacin which could result in a higher serum level.
Alprenolol
Varicella Zoster Vaccine (Live/attenuated)
The therapeutic efficacy of Varicella Zoster Vaccine (Live/attenuated) can be decreased when used in combination with Darunavir.
Alprenolol
Adenovirus type 7 vaccine live
The therapeutic efficacy of Adenovirus type 7 vaccine live can be decreased when used in combination with Darunavir.
Alprenolol
Vibrio cholerae CVD 103-HgR strain live antigen
The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Darunavir.
Alprenolol
Human adenovirus e serotype 4 strain cl-68578 antigen
The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Darunavir.
Alprenolol
BCG vaccine
The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Darunavir.
Alprenolol
Bacillus calmette-guerin substrain danish 1331 live antigen
The therapeutic efficacy of Bacillus calmette-guerin substrain danish 1331 live antigen can be decreased when used in combination with Darunavir.
Alprenolol
Typhoid Vaccine Live
The therapeutic efficacy of Typhoid Vaccine Live can be decreased when used in combination with Darunavir.
Alprenolol
Anthrax vaccine
The therapeutic efficacy of Anthrax vaccine can be decreased when used in combination with Darunavir.
Alprenolol
Yellow Fever Vaccine
The therapeutic efficacy of Yellow Fever Vaccine can be decreased when used in combination with Darunavir.